The transcatheter embolization and occlusion devices market size was valued at USD 5.46 billion in 2024 and is expected to reach USD 10.57 billion by 2032, growing at a CAGR of 8.66% over the forecast period of 2025-2032.
The global transcatheter embolization and occlusion devices market is expected to grow steadily, mainly attributed to the increasing cases of cancer, vascular disorders, and neurovascular diseases across the globe. Moreover, the upsurge in demand for minimally invasive techniques, progress in developing novel embolic agents, and increasing availability of interventional radiology infrastructure are additional factors in boosting the transcatheter embolization and occlusion devices market growth. Continued demand in the market is anticipated with increasing adoption in emerging economies and increasing application in oncology and neurology. Long-term market growth outlook is supported by favorable reimbursement policies and clinical success of embolization procedures.
The U.S. transcatheter embolization and occlusion devices market size was valued at USD 1.58 billion in 2024 and is expected to reach USD 2.98 billion by 2032, growing at a CAGR of 8.28% over the forecast period of 2025-2032.
North America, comprising the U.S. and Canada, will remain the largest market for transcatheter embolization and occlusion devices over the estimated period. The growth can be attributed to advanced healthcare infrastructure in the region, the growing preference for minimally invasive procedures, and the adoption of many novel embolization technologies, particularly in the U.S. Thyrocare has its leadership in the region backed by high procedural volume for neurovascular, oncology, and peripheral interventions.
Drivers
Market Growth is Driven by the Rapidly Increasing Prevalence of Cancer and Vascular Diseases
The rising burden of cancer, particularly hepatocellular carcinoma, renal tumors, and gynecological malignancies, represents one of the key drivers for the increasing transcatheter embolization demand. Transarterial Chemoembolization (TACE) and Transarterial Radioembolization (TARE) have ever since defined as the standard treatment modalities for inoperable tumors, especially in the liver. At the same time, vascular anomalies, such as aneurysms, arteriovenous malformations (AVMs), and chronic hemorrhages, are becoming a major economic burden, requiring embolic agents for safe, minimally invasive treatment. With the global increase in cancer and vascular diseases, there is a growing demand for localized and targeted occlusion devices.
Pre-operative Planning and Real-time Guidance for Embolization Procedures with AI-assisted Imaging Innovation (via CBCT and Fusion Imaging) Leading to an Increase in Precision and Clinical Outcomes
The Market is Driven by Technological Advancements in Embolic Materials
Advancements in embolic device technology enable higher success rates, improved safety profiles, and more targeted treatments. These consist of detachable coils, hydrogel-coated coils, non-adhesive liquid embolics, including Onyx and calibrated microspheres, which permit selective embolization of edematous vessels. This has allowed a wider range of conditions to be addressed with an overall lower risk of non-target embolization, improved imaging visibility, and more reproducible particle distribution. These advancements improve clinical outcomes but also promote embolization in an expanded array of medical indications, such as oncology, urology, and neurology, which in turn propels the growth of the market.
JUNE 2025 — Embolization, Inc., a medical device company, recently achieved FDA 510(k) clearance for its Nitinol-Enhanced device (NED). The NED is intended for use in peripheral vasculature for arterial and venous embolization and represents an important addition to the company's portfolio of vascular embolization solutions.
Restraint
High Cost of Devices and Procedures is Restraining the Market from Growing
High costs of the devices and procedures are one of the major restraining factors during the forecast period in the transcatheter embolization and occlusion devices market. Embolic material such as detachable coils, microspheres, liquid embolics (e.g., Onyx, NBCA), and advanced microcatheters is extremely costly. Moreover, these approaches usually involve complex imaging equipment, specialized interventional radiologists, and operating room facilities, which can substantially elevate the cost of care.
In developing or underfunded healthcare systems, this becomes an enormous obstacle as hospitals and clinics lacking the infrastructure or backing from government reimbursement are unlikely to be able to adopt these therapies at scale. Consequently, access to embolization therapies is often limited in LMIC markets due to prohibitive costs, which in turn limits the overall market enablement potential.
By Device Type
The non-coil segment dominated the transcatheter embolization and occlusion devices market share with 51.4% in 2024, as it has wide applicability compared to other products, contributing the major market share in treating complicated vascular abnormalities and tumors, having clinically proven benefits. Novel devices (liquid embolics, vascular plugs, microspheres) pave the way for increased precision, reduced risk of migration, and greater versatility across anatomies. The proven efficiency in their targeted tumor embolization and for liver cancer treatment (TACE—Transarterial Chemoembolization) has impelled their considerable uptake. Moreover, their position has been consolidated with growing usage in peripheral interventions and progressive delivery systems for different non-coil technologies.
The coils segment is anticipated to grow steadily during the forecast period, owing to increasing volumes of neurovascular procedures and design refinements in coils over the period. Coils have been the gold standard for treating cerebral aneurysms and arteriovenous malformations (AVMs) for decades, whilst there remains a long history supporting the safety and efficacy of coils. For instance, hydrogel-coated coils, detachable coils are the innovations wherein functional use is considered to increase the procedural outcome and also expand their applicability in newer therapeutic areas, fuelling the growth of the market in developed and emerging markets.
By Application
The oncology segment dominated the transcatheter embolization and occlusion devices market with a 61.20% market share due to the high standard application of embolization procedures in the treatment of cancer, especially for unresectable tumors. Methods such as transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) are widely reported for liver cancer and solid tumor sites to regionally occlude the blood supply to the tumor site. The increasing global incidence of cancer, with a rise in hepatocellular carcinoma, alignment of awareness regarding embolization, and innovation in transcatheter targeted embolic agents constitute major contributing factors for the growing adoption of embolization as a standard procedure in oncology care.
The neurology segment is anticipated to grow at the fastest rate during the forecast period, owing to the increasing prevalence of cerebral aneurysms, strokes, and arteriovenous malformations (AVMs). Coils and liquid embolics for neurovascular embolization procedures are becoming increasingly popular due to their safety, specificity, and good results with relatively minimally invasive procedures. Technological innovations in neuro-interventional devices, expanding access to specialized care, and increased clinical training in endovascular neurology are rapidly stimulating the use of embolization for both developed and emerging markets.
By End Use
The hospitals segment dominated the transcatheter embolization and occlusion devices market in 2024 with a 64.3% market share due to the availability of advanced imaging systems and specialist interventional radiology units, and trained medical personnel. As the centers at which the most complex embolization procedures are performed, hospitals often receive patients with the most severe cases, such as tumors, aneurysms, or trauma-related vascular injuries. As hospitals can accommodate higher patient volume, have access to multidisciplinary care teams, and offer intensive post-procedural care, they represent the leading market preference for these procedures.
The ambulatory surgical centers (ASCs) segment is projected to register the fastest CAGR during the forecast period, due to the increasing need for cost-effective adult soft tissue surgical procedures with minimum trauma and faster recovery times. Ambulatory Surgery Centers (ASCs) provide a more convenient setting for some of the embolization cases (peripheral vascular/oncological cases) compared to hospital admission. Catheter-based technology advancements, patient-friendly workflows, and broader insurance coverage for outpatient procedures are accelerating the transition to ASCs. The phenomenon is well visible in the developed regions where healthcare providers are moving towards efficient and rapid access models to lower the costs of inpatient treatment.
North America dominated the transcatheter embolization and occlusion devices market with a 38.12% market share in 2024, due to the advanced healthcare infrastructure, broad accessibility of interventional radiology services, and a high incidence of vascular and oncologic conditions. This supremacy in the region is supported by the presence of global players in the medical device industry, favorable reimbursement policies, and high adoption rates for these minimally invasive technologies. Furthermore, the demand for embolization devices among hospitals and specialty centers is supported by the ascendance of awareness, procedural volumes, and favorable clinical guidelines.
The transcatheter embolization and occlusion devices market trends in Asia Pacific are anticipated to grow fastest with a 9.25% CAGR owing to increasing healthcare expenditures, a rise in cancer and vascular diseases, and higher availability of advanced medical technologies. The rising healthcare infrastructure, growing penetration of insurance, and increasing public awareness about interventional procedures are driving market growth in Countries such as China, India, Japan, etc. In addition, training professionals in health care and government initiatives to promote minimally invasive care is enhancing the growth of the regional market.
The transcatheter embolization and occlusion devices market analysis in Europe is growing due to the increasing volume of minimally invasive procedures in the field of oncology, vascular care, and neurology. It is boosted by developed healthcare systems, an ageing population, and an increasing number of chronic diseases such as cancer and peripheral artery disease. Moreover, positive regulatory assistance, rising clinical trials in interventional radiology, and leading medical device companies provide an impetus for widespread utilization of the technology in hospitals and specialty clinics across Europe.
The transcatheter embolization and occlusion devices market in Latin America and the Middle East & Africa (MEA) is anticipated to witness moderate growth over the forecast period, owing to improving healthcare infrastructure and rising awareness of interventional radiology procedures. Although these regions have constraints such as accessibility to advanced medical apparatus and expertise, the growing governmental investments, escalating disease burden, and slow acceptance of minimally invasive therapies have kept the markets expanding steadily for them. Moreover, the participation of the private sector and medical tourism in some of the cities is promoting the market.
Boston Scientific Corporation, Medtronic, Inc., Stryker Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, DePuy Synthes (J&J), Cordis Corporation, St. Jude Medical, Sirtex Medical, and other players.
In April 2022, Boston Scientific announced that it had received FDA510(k) clearance for its EMBOLD Fibered Detachable Coil for use in occlusion or embolization of blood vessels within the peripheral vasculature to restrict or block blood flow. With the University of Alabama at Birmingham performing the first clinical procedure earlier this week, the device has achieved an important milestone in peripheral embolization therapy.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 5.46 Billion |
| Market Size by 2032 | USD 10.57 Billion |
| CAGR | CAGR of 8.66% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Device Type (Non-coil, Coils) • By Application (Oncology, Peripheral Vascular Disease, Neurology, Urology, Other Applications) • By End Use (Hospitals, Ambulatory Surgical Centers, Other End Use) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Boston Scientific Corporation, Medtronic, Inc., Stryker Corporation, Abbott Laboratories, Cook Medical, Terumo Corporation, DePuy Synthes (J&J), Cordis Corporation, St. Jude Medical, Sirtex Medical, and other players. |
Ans: The Transcatheter Embolization and Occlusion Devices Market is expected to grow at a CAGR of 8.66% from 2025 to 2032.
Ans: The Transcatheter Embolization and Occlusion Devices Market was USD 5.46 billion in 2024 and is expected to reach USD 10.57 billion by 2032.
Ans: Market growth is driven by the rapidly increasing prevalence of cancer and vascular diseases.
Ans: The “Non-coil” segment dominated the Transcatheter Embolization and Occlusion Devices Market.
Ans: North America dominated the Transcatheter Embolization and Occlusion Devices Market in 2024.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2024)
5.2 Incidence and Prevalence (2024)
5.3 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket) – 2024
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Transcatheter Embolization and Occlusion Devices Market Segmentation By Device Type
7.1 Chapter Overview
7.2 Non-Coil
7.2.1 Non-coil Market Trends Analysis (2021-2032)
7.2.2 Non-coil Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Flow diverting devices
7.2.3.1 Non-coil Market Trends Analysis (2021-2032)
7.2.3.2 Non-coil Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Embolization particles
7.2.4.1 Non-coil Market Trends Analysis (2021-2032)
7.2.4.2 Non-coil Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Liquid embolics
7.2.5.1 Non-coil Market Trends Analysis (2021-2032)
7.2.5.2 Non-coil Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Other non-coil device types
7.2.6.1 Non-coil Market Trends Analysis (2021-2032)
7.2.6.2 Non-coil Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Coils
7.3.1 Coils Market Trends Analysis (2021-2032)
7.3.2 Coils Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Pushable coils
7.3.3.1 Pushable Coils Market Trends Analysis (2021-2032)
7.3.2 Pushable Coils Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Detachable coils
7.3.4.1 Detachable Coils Market Trends Analysis (2021-2032)
7.3.4.2 Detachable coils Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Transcatheter Embolization and Occlusion Devices Market Segmentation By Application
8.1 Chapter Overview
8.2 Oncology
8.2.1 Oncology Market Trend Analysis (2021-2032)
8.2.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Peripheral vascular disease
8.3.1 Peripheral vascular disease Market Trends Analysis (2021-2032)
8.3.2 Peripheral vascular disease Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Neurology
8.4.1 Neurology Market Trends Analysis (2021-2032)
8.4.2 Neurology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Urology
8.6.1 Urology Market Trends Analysis (2021-2032)
8.6.2 Urology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Other applications
8.6.1 Other applications Market Trends Analysis (2021-2032)
8.6.2 Other applications Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Transcatheter Embolization and Occlusion Devices Market Segmentation By End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2021-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ambulatory surgical centers
9.3.1 Ambulatory Surgical Centers Market Trends Analysis (2021-2032)
9.3.2 Ambulatory Surgical Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Other end use
9.4.1 Other end use Market Trends Analysis (2021-2032)
9.4.2 Other end use Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.4 North America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.2.5 North America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.6.2 USA Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.2.6.3 USA Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.7.2 Canada Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.2.7.3 Canada Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.8.2 Mexico Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.2.8.3 Mexico Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.4 Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.5 Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User(2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.1.6.2 Germany Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.1.6.3 Germany Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.7.2 France a Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.7.3 France Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.8.2 UK Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.8.3 UK Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.9.2 Italy Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.9.3 Italy Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.10.2 Spain Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.10.3 Spain Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.12.3 Poland Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.12.3 Poland Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.13.2 Turkey Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.13.3 Turkey Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User(2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.4 Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.5 Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.6.2 China Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.6.3 China Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.7.2 India Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.7.3 India Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.8.2 Japan Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.8.3 Japan Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.9.2 South Korea Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.9.3 South Korea Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.10.2 Singapore Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.10.3 Singapore Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.11.2 Australia Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.11.3 Australia Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3Middle East and Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.6.2 UAE Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.5.6.3 UAE Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.8.2 Qatar Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.5.8.3 Qatar Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.9 2 South Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts By Device Type (2021-2032) (USD Billion)
10.5.9 3 South Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.4 Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.6.5 Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.6.2 Brazil Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.6.6.3 Brazil Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.7.2 Argentina Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.6.7.3 Argentina Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By Device Type (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Transcatheter Embolization and Occlusion Devices Market Estimates and Forecasts, By End User (2021-2032) (USD Billion)
12. Company Profiles
12.1 Boston Scientific Corporation
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Medtronic
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Stryker Corporation
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Abbott Laboratories
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Cook Medical
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Terumo Corporation
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 DePuy Synthes (J&J),
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Cordis Corporation
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9, St. Jude Medical
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Sirtex Medical
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Device Type
Non-coil
Flow diverting devices
Embolization particles
Liquid embolics
Other non-coil device types
Coils
Pushable coils
Detachable coils
By Application
Oncology
Peripheral vascular disease
Neurology
Urology
Other applications
By End Use
Hospitals
Ambulatory surgical centers
Other end use
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players